Skip to content
— CH. 1 · THE DREAMER'S DISCOVERY —

Morphine

~4 min read · Ch. 1 of 6
6 sections
  • In December 1804, a German pharmacist named Friedrich Sertürner isolated a white crystalline substance from the dried latex of opium poppies in Paderborn. He called this new compound morphium after Morpheus, the Greek god of dreams, because it induced sleep. This marked the first time an active alkaloid was extracted from a plant for medicinal use. Sertürner tested the substance on himself and three young boys, along with dogs and a mouse. All four human subjects nearly died during these early experiments. The substance proved to be six times stronger than raw opium. Sertürner later warned that he considered it his duty to alert others to the terrible effects of his discovery. He became addicted to the drug himself while trying to study its properties.

  • Morphine serves as the primary analgesic for acute pain conditions like myocardial infarction and kidney stones. It is also used during labor to manage severe pain. The duration of its effect lasts between three to seven hours depending on the method of administration. When given intravenously, maximum effect occurs within about twenty minutes. Oral administration takes approximately sixty minutes to reach peak levels. Long-acting formulations such as MS Contin and Kadian allow for once-daily dosing. A 2016 Cochrane review confirmed morphine effectively relieves cancer pain. It reduces shortness of breath in patients with advanced cancer or end-stage cardiorespiratory diseases when given at low doses. Side effects include drowsiness, nausea, constipation, and sweating. Serious complications can involve decreased respiratory effort and vomiting. Constipation results from reduced gut motility mediated by mu-opioid receptors in the intestinal tract.

  • The molecule binds primarily to mu-opioid receptors located in the posterior amygdala, hypothalamus, thalamus, and spinal cord laminae I and II. Activation of these receptors produces analgesia, sedation, euphoria, and physical dependence. Morphine also interacts with kappa and delta opioid receptors. The drug activates a specific group of neurons called the morphine ensemble in the rostral ventromedial medulla. These neurons connect to inhibitory neurons that release GABA and galanin. Increasing levels of BDNF enhances the pain-relieving effect even at lower doses. Chronic use alters gene expression related to mitochondrial respiration and cytoskeleton proteins. Dendritic cells display opiate receptors and produce cytokines like interleukin-12 when chronically exposed to morphine. This immune response may reduce resistance to infection and impair wound healing after injury.

  • Repeated administration leads to tolerance where higher doses are needed for the same effect. Cessation creates a prototypical opioid withdrawal syndrome that is not fatal but highly distressing. Symptoms progress through six stages over several days. Stage one begins within six hours showing craving anxiety and perspiration. By stage four between twenty-four and thirty-six hours severe cramping and vomiting occur. Peak symptoms appear between forty-eight and ninety-six hours before subsiding around eight to twelve days later. Physical withdrawal includes watery eyes runny nose yawning insomnia and body aches. Psychological dependence persists long after physical needs pass. Users experience depression anxiety mood swings and forgetfulness. Relapse rates reach up to ninety-eight percent without behavioral intervention. Blood pressure and heart rate increase significantly during acute withdrawal potentially causing heart attacks or strokes.

  • Marshall D. Gates Jr. developed the first total synthesis of morphine in 1952 using coal tar as a starting material. The structural formula was determined by Robert Robinson by 1925. Most commercial morphine comes from poppy straw or latex extraction rather than chemical synthesis. Heroin known chemically as diacetylmorphine was synthesized from morphine in 1874 and marketed by Bayer in 1898. It crosses the blood-brain barrier faster due to lipid solubility making it more potent. Over two hundred fifty derivatives have been created since the late nineteenth century. These include hydromorphone oxycodone and codeine which are used for pain management. Some modifications produce non-narcotic drugs like emetics or antitussives. Chemical salts such as hydrochloride and sulfate make the drug water-soluble for injection. Heroin remains a Schedule I controlled substance in the United States but is sanctioned in the UK and Canada.

Continue Browsing

Common questions

When did Friedrich Sertürner isolate morphine from opium poppies?

Friedrich Sertürner isolated morphine in December 1804. He extracted the white crystalline substance from dried latex of opium poppies in Paderborn. This event marked the first time an active alkaloid was extracted from a plant for medicinal use.

What medical conditions does morphine treat effectively?

Morphine serves as the primary analgesic for acute pain conditions like myocardial infarction and kidney stones. It is also used during labor to manage severe pain and relieves cancer pain according to a 2016 Cochrane review. The drug reduces shortness of breath in patients with advanced cancer or end-stage cardiorespiratory diseases when given at low doses.

How long does the effect of morphine last after administration?

The duration of its effect lasts between three to seven hours depending on the method of administration. When given intravenously maximum effect occurs within about twenty minutes while oral administration takes approximately sixty minutes to reach peak levels. Long-acting formulations such as MS Contin and Kadian allow for once-daily dosing.

When did Marshall D. Gates Jr develop the first total synthesis of morphine?

Marshall D. Gates Jr developed the first total synthesis of morphine in 1952 using coal tar as a starting material. The structural formula was determined by Robert Robinson by 1925. Most commercial morphine comes from poppy straw or latex extraction rather than chemical synthesis.

What were the global production statistics for morphine in 2013?

In 2013 approximately five hundred twenty-three tons of morphine were produced globally. Only about forty-five tons were used directly for pain relief while seventy percent went into making other opioids. Six countries including Australia Canada France Germany the UK and the US consumed seventy-nine percent of the world supply.